Harshi Peiris: 2026 Cholesterol Guidelines Bring Earlier and More Precise Risk Assessment
Harshi Peiris, Science Writer and Communicator, shared JAMA‘s post on X:
“Big update in heart health:
The 2026 cholesterol guidelines just got a major overhaul – and it changes when doctors start checking your risk.
Dyslipidemia is when your blood fats (cholesterol, triglycerides) are out of healthy range, quietly raising your risk of heart attack and stroke.
New guidelines say: catch it earlier, test smarter, treat more precisely.
Have you had your cholesterol checked in the last year?”
JAMA shared a post on X about a recent article by Anum Saeed et al., adding:
“JAMA Clinical Guidelines Synopsis:
The 2026 Dyslipidemia guideline recommends lifetime measurement of Lp(a) in all adults and earlier ASCVD risk assessment with the PREVENT calculator starting at age 30.”
Title: Dyslipidemia Evaluation and Management
Authors: Anum Saeed, Andrew M. Davis, Amber E. Johnson
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?